Published 1 Dec 2022
David DEMAILLY, Ph. D shares his vision on the API business as a whole and what sustainability means for Aspen API in an interview with Pharma Tech Outlook.
Go to Pharma Tech Outlook’s website by clicking on the link and read all about David’s vision.
